The content on this site is intended for healthcare professionals only
Cancer genes differ in different parts of a tumour
Targeting DNA damage response and repair excluding PARP for triple negative breast cancer
Molecular characterisation of breast cancer: the mutational landscape
New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer
Metabolism in malignant tumors: a new approach for treating breast cancer
Criteria required before implementation of whole genome arrays in clinical practice
Evidence for TORC1 activation marker as a predictive factor for everolimus efficacy in metastatic breast cancer
Prognostic significance of progesterone receptor-positive tumour cells within luminal A breast cancer
EONS 2012 lifetime achievement award
Impact and management of malignant wounds
Patient perspective on cancer and pregnancy (Italian)
Communication in genetics and genomics
